Routinely collected data: a path to assess safety of human mesenchymal stromal cell transplantation in randomized controlled trials
Amir Hossein Norooznezhad · 2025
Read Routinely collected data: a path to assess safety of human mesenchymal stromal cell transplantation in randomized controlled trials by Amir Hossein Norooznezhad (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12754955.txt.
Description
Amir Hossein Norooznezhad discussed cell transplant safety data in two thousand twenty-five. Mesenchymal stromal cells feature in many clinical trials. Trial numbers keep growing quickly. Safety questions remain open despite some reassuring evidence. One worry is a possible cancer-promoting effect. Routine health records may help resolve it.
Trials alone struggle with very long follow-up. Routinely collected data fill that gap cheaply. Such records already exist inside health systems. Recent trial patterns suggest the approach is feasible. Linking trial patients to routine records extends safety watching. Rare late harms become detectable at scale. Regulators gain a practical surveillance path.
Catalog record
| CREATOR | Amir Hossein Norooznezhad |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 9 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |